PLATELET-AGGREGATION, BETA-THROMBOGLOBULIN AND PLATELET FACTOR-4 IN DIABETES-MELLITUS AND IN PATIENTS WITH VASCULOPATHY
- 1 January 1984
- journal article
- research article
- Vol. 52 (3) , 236-239
Abstract
There were 155 subjects studied: 48 normals, 36 diabetics without complications, 44 with complications and 27 patients with macroangiopathy. .beta.-Thromboglobulin (.beta.-TG) and platelet factor 4 (PF4) were elevated in the patients groups. There was no correlation between the plasma levels of .beta.-TG and the stages of either retinopathy, macroangiopathy or nephropathy. The difference was more marked between normals and diabetics with neuropathy (P = 0.026). The aggregation response to ADP and platelet activating fctor (PAF) was enhanced at lower stimulator concentrations. Using the .beta.-TG, PF4 and aggregation values the discriminant analysis allows a distinction of several subgroups especially with nephropathy and neuropathy.This publication has 7 references indexed in Scilit:
- Beta Thromboglobulin and Glycosylated Haemoglobin in Diabetes MellitusScandinavian Journal of Haematology, 2009
- Fifteen Coagulation and Fibrinolysis Parameters in Diabetes Mellitus and in Patients with VasculopathyThrombosis and Haemostasis, 1984
- The Contact Phase of Blood Coagulation in Diabetes Mellitus and in Patients with VasculopathyThrombosis and Haemostasis, 1984
- Platelet function in diabetes mellitus in relationship to complications, glycosylated haemoglobin and serum lipoproteinsEuropean Journal of Clinical Investigation, 1981
- INCREASED PLATELET THROMBOXANE SYNTHESIS IN DIABETES-MELLITUS1981
- FACTORS AFFECTING PLASMA BETA-THROMBOGLOBULIN IN DIABETES-MELLITUS1980
- Plasma beta-thromboglobulin in diabetes mellitusDiabetes, 1977